跳至主要内容
临床试验/IRCT20140307016876N3
IRCT20140307016876N3招募中3 期

Study of the effect of ginger on biochemical markers and imaging of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus.

Shiraz University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • The patient with type 2 diabetes mellitus
  • Fasting blood sugar between 80 and 130 and HbA1C is less than 7%
  • Age range 25 to 65 years
  • Body mass index (BMI) ranges from 22 to 35 kg / m 2
  • The serum alanine transaminase level (ALT) is more than one and a half times higher than normal (ie, in men more than 45 and in women more than or equal to 29 units per liter according to the latest definition of abnormal ALT in men and women)
  • Having a high-fatty liver disease (moderate to high) in liver ultrasound
  • Conscious informed consent of patients to participate in the study

排除标准

  • Liver failure (acute or chronic)
  • Hepatitis such as autoimmune hepatitis, viral hepatitis B and C (active or inactive), Wilson's disease and ...
  • Hypo and hyperthyroidism
  • Renal failure (creatinin above 1.5 mg / dL)
  • Diabetes-induced retinopathy
  • Diabetic Nephropathy
  • alcohol consumption
  • Any malignancy (treated or not)
  • Taking warfarin
  • Taking contraceptives, ursodeoxycholic acid, glucocorticoids, statins, probiotics, vitamin E in the last three months
  • History of allergy to ginger
  • Addiction and drug abuse
  • Heart disease
  • History of allergy

研究者

相似试验